Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuclid vs Clopidogrel in Clopidogrel-Resistant Carotid Stenting
NCT02133989Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jun 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Diabend-M in carotid artery stenosis (2 arms), sponsored by Samsung Medical Center. Primary endpoint: New ischemic lesion on diffusion-weighted imaging (DWI) at 24 hours. Status: unknown.
02
Drugs
Diabend-M
03
Conditions
carotid artery stenosis
Beyond the preview
Go deeper on NCT02133989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133989.